120 related articles for article (PubMed ID: 8713696)
1. Measurement of faecal alpha 1-antitrypsin: methodologies and clinical application.
Choudhary S; Gibson PR; Deacon MC; Young GP
J Gastroenterol Hepatol; 1996 Apr; 11(4):311-8. PubMed ID: 8713696
[TBL] [Abstract][Full Text] [Related]
2. Value of faecal alpha-1-antitrypsin, haemoglobin and a chemical occult blood test in the detection of gastrointestinal disease.
Moran A; Lawson N; Morrow R; Jones A; Asquith P
Clin Chim Acta; 1993 Aug; 217(2):153-61. PubMed ID: 8261624
[TBL] [Abstract][Full Text] [Related]
3. Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders.
Strygler B; Nicar MJ; Santangelo WC; Porter JL; Fordtran JS
Gastroenterology; 1990 Nov; 99(5):1380-7. PubMed ID: 2210245
[TBL] [Abstract][Full Text] [Related]
4. Reassessment of faecal alpha-1-antitrypsin excretion for use as screening test for intestinal protein loss.
Quigley EM; Ross IN; Haeney MR; Holbrook IB; Marsh MN
J Clin Pathol; 1987 Jan; 40(1):61-6. PubMed ID: 3493263
[TBL] [Abstract][Full Text] [Related]
5. Fecal alpha 1-antitrypsin detection of colorectal neoplasia. An evaluation using HemoQuant.
Moran A; Robinson M; Lawson N; Stanley J; Jones AF; Hardcastle JD
Dig Dis Sci; 1995 Dec; 40(12):2522-5. PubMed ID: 8536506
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of a guaiac occult blood test and faecal alpha 1-antitrypsin.
Moran A; Husband D; Jones AF; Asquith P
Gut; 1995 Jan; 36(1):87-9. PubMed ID: 7890241
[TBL] [Abstract][Full Text] [Related]
7. Random fecal alpha-1-antitrypsin concentration in children with gastrointestinal disease.
Thomas DW; Sinatra FR; Merritt RJ
Gastroenterology; 1981 Apr; 80(4):776-82. PubMed ID: 6970702
[TBL] [Abstract][Full Text] [Related]
8. The usefulness of faecal haemoglobin, albumin and alpha-1-antitrypsin in the detection of gastrointestinal bleeding.
Morrow RJ; Lawson N; Hussaini SH; Asquith P
Ann Clin Biochem; 1990 May; 27 ( Pt 3)():208-12. PubMed ID: 2200332
[TBL] [Abstract][Full Text] [Related]
9. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
Schwery S; Meyenberger C; Ammann R; Wirth HP
Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
[TBL] [Abstract][Full Text] [Related]
10. Faecal alpha 1 antitrypsin as a marker of gastrointestinal disease in HIV antibody positive individuals.
Sharpstone D; Rowbottom A; Nelson M; Gazzard B
Gut; 1996 Feb; 38(2):206-10. PubMed ID: 8801198
[TBL] [Abstract][Full Text] [Related]
11. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
Boege F; Fischbach W
Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
[TBL] [Abstract][Full Text] [Related]
12. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
Fischbach W; Deubel M; Boege F; Mössner J
Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
[TBL] [Abstract][Full Text] [Related]
13. Faecal alpha 1-antitrypsin concentration in the diagnosis and management of patients with pouchitis.
Boerr LA; Sambuelli AM; Sugai E; Graziano A; Valero J; Kogan Z; Bai J
Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):129-33. PubMed ID: 7712304
[TBL] [Abstract][Full Text] [Related]
14. Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases.
Saitoh O; Matsumoto H; Sugimori K; Sugi K; Nakagawa K; Miyoshi H; Hirata I; Matsuse R; Uchida K; Ohshiba S
Digestion; 1995; 56(1):67-75. PubMed ID: 7895935
[TBL] [Abstract][Full Text] [Related]
15. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.
Fischbach W; Becker W; Mössner J; Koch W; Reiners C
Gut; 1987 Apr; 28(4):386-93. PubMed ID: 3495470
[TBL] [Abstract][Full Text] [Related]
16. Detection of colorectal cancer by faecal alpha 1-antitrypsin.
Moran A; Radley S; Neoptolemos J; Jones AF; Asquith P
Ann Clin Biochem; 1993 Jan; 30 ( Pt 1)():28-33. PubMed ID: 8434864
[TBL] [Abstract][Full Text] [Related]
17. Is faecal alpha 1-antitrypsin excretion a reliable screening test for protein-losing enteropathy?
Haeney MR; Fields J; Carter RA; Thompson RA; Asquith P
Lancet; 1979 Dec; 2(8153):1161-2. PubMed ID: 91891
[TBL] [Abstract][Full Text] [Related]
18. Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of Indonesian infants fed breast milk or probiotic/prebiotic-supplemented formula.
Oswari H; Prayitno L; Dwipoerwantoro PG; Firmansyah A; Makrides M; Lawley B; Kuhn-Sherlock B; Cleghorn G; Tannock GW
J Paediatr Child Health; 2013 Dec; 49(12):1032-9. PubMed ID: 23782263
[TBL] [Abstract][Full Text] [Related]
19. Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance.
Karbach U; Ewe K
Z Gastroenterol; 1989 Jul; 27(7):362-5. PubMed ID: 2475983
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of performance of measurement of faecal α(1)-antitrypsin clearance and technetium-99m human serum albumin scintigraphy in protein-losing enteropathy.
Chau TN; Mok MY; Chan EY; Luk WH; Lai KB; Li FT; Leung VK; Wong R
Digestion; 2011; 84(3):199-206. PubMed ID: 21757911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
